Pandemic cuts adult vaccination levels by 12%, bucking positive trend of past decade

The arrival of the COVID-19 pandemic hampers the past decade’s positive developments in adult vaccination.Vaccination coverage in adults against influenza, diphtheria and tetanus (Td), diphtheria, tetanus and pertussis (TDaP), hepatitis B, herpes zoster and other diseases after a peak of 400 million doses in the year of the pandemic outbreak rate and pneumococcus 12% decline between 2020 and 2022, up to 351 million. This is clearly shown in the latest GSK-funded report, Global Adult Vaccination Trends: The Impact of COVID-19, published by consultancy Iqvia.

Adult vaccination coverage is almost always much lower than that of children. Although the progress made in adult vaccination between 2013 and 2019 is commendable, the overall level of adult vaccination coverage remains low, suggesting a need for further improvement. ’ said the report prepared by the consultancy firm.

94,000 premature deaths per year in Europe Due to vaccine-preventable diseases and massive hospitalizations. “From an economic and health perspective, vaccine-preventable diseases pose a significant burden on individuals, health systems, and society as a whole,” the document states. The World Health Organization estimates that seasonal influenza epidemics alone kill three to five hundred Thousands of people were hospitalized, 290,000 to 650,000 deaths.

Older persons constitute an increasing proportion of the world’s population. Individuals aged 50 and over are increasingly susceptible to infectious diseases and are at increased risk of comorbidities due to age-related decline in immunity. In fact, expected by 2030 Population aged 60 and over grew by more than a third to 1.4 billion.

The consultant’s report also reflects that the epidemic has most negative impact Adult Vaccine Dosage Countries with a low-to-medium human development index (IDH).Despite positive trends prior to the outbreak, it is worth noting that adult vaccination coverage remains suboptimal in all countries and attention needs to be paid to increasing global adult immunization rates

Adult Vaccine Spending

he Spending on adult vaccines is only a tiny fraction of total spending medical expenses General Medicines and Vaccines. In more developed regions, for example, it accounts for less than 2% of total spending on pharmaceuticals. Europe and North America saw modest increases of 0.2 to 0.5 percentage points over time. But in other countries and regions, the proportion is much lower, at 0.1% to 0.5%.

Vaccination also helps fight antimicrobial resistance, which is considered a silent epidemic. In 2019, 1.27 million people worldwide died from multidrug-resistant bacteria. Of these, 10% of European deaths during this period occurred in Spain.Abuse of antibiotics negatively impacts human health By 2050, they are projected to be the leading cause of death worldwidekilling more than 10 million people every year.

The use of vaccines to prevent bacterial and viral infectious diseases can reduce antibiotic consumption and suppress levels of resistance. But adult vaccines could also have broader knock-on effects, as they could use limited resources more efficiently by preventing disease and reducing pressure on hospitals, doctors and long-term care systems. “The report.

You may also like…

Source link

Leave a Comment